LFG
PCRX icon

Larson Financial Group’s Pacira BioSciences PCRX Stock Holding History

Larson Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.9K Buy
3,898
+1,261
+48% +$29.8K ﹤0.01% 1191
2026
Q1 		$59.6K Buy
+2,637
New +$58.6K ﹤0.01% 1259
2025
Q3 		– Sell
-6
Closed -$143 – 3590
2025
Q2 		$143 Buy
6
+1
+20% +$25 ﹤0.01% 3116
2025
Q1 		$124 Hold
5
– – ﹤0.01% 2880
2024
Q4 		$94 Hold
5
– – ﹤0.01% 2616
2024
Q3 		$75 Hold
5
– – ﹤0.01% 2591
2024
Q2 		$143 Buy
+5
New +$142 ﹤0.01% 2169
2023
Q1 		– Sell
-66
Closed -$2.55K – 1589
2022
Q4 		$2.55K Buy
+66
New +$3.21K ﹤0.01% 1154

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's PCRX Position: Q2 2026 in Review

Larson Financial Group increased its Pacira BioSciences (PCRX) stake by 48% in Q2 2026, buying an estimated $29.8K and bringing the position to 3,898 shares worth $98.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Larson Financial Group first reported a position in PCRX in Q4 2022 and has held it in 8 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Larson Financial Group held 3,898 shares of Pacira BioSciences worth $98.9K as of Q2 2026.
  • Larson Financial Group bought 1,261 Pacira BioSciences shares in Q2 2026, an estimated $29.8K.
  • Pacira BioSciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1191 holding.
  • Larson Financial Group first reported a position in Pacira BioSciences in Q4 2022 and has held it in 8 quarters since.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.